Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Neutral

B

HilleVax, Inc. Common Stock (HLVX)

Biological Products, (no Disgnostic Substances)

https://www.hillevax.com

HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

321 HARRISON AVE, SUITE 500
BOSTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/29/2022

Market Cap

90,643,440

Shares Outstanding

48,440,000

Weighted SO

48,437,001

Total Employees

N/A

Upcoming Earnings

08/12/2024

Beta

0.7940

Last Div

0.0000

Range

1.55-20.22

Chg

0.0107

Avg Vol

1084656

Mkt Cap

90643440

Exch

NASDAQ

Country

US

Phone

617 213 5054

DCF Diff

-2.2661

DCF

4.0761

Div Yield

0.0000

P/S

31.6492

EV Multiple

-0.2357

P/FV

0.4369

Div Yield %

0.0000

P/E

-0.5730

PEG

-0.0103

Payout

0.0000

Current Ratio

5.1363

Quick Ratio

5.1363

Cash Ratio

2.2057

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

488.1035

CCC

-488.1035

Gross Margin

-0.0052

Op Margin

-50.0705

Pretax Margin

-54.5642

Net Margin

-54.5642

Eff Tax Rate

-0.0174

ROA

-0.5643

ROE

-0.6201

ROCE

-0.6296

NI/EBT

1.0000

EBT/EBIT

1.0897

EBIT/Rev

-50.0705

Debt Ratio

0.1844

D/E

0.2492

LT Debt/Cap

0.0965

Total Debt/Cap

0.1995

Int Coverage

71701.0000

CF/Debt

-2.1770

Equity Multi

1.3513

Rec Turnover

0.0000

Pay Turnover

0.7478

Inv Turnover

0.0000

FA Turnover

0.1259

Asset Turnover

0.0103

OCF/Share

-2.2610

FCF/Share

-2.6056

Cash/Share

4.9826

OCF/Sales

-38.8244

FCF/OCF

1.1524

CF Coverage

-2.1770

ST Coverage

-3.8105

CapEx Coverage

-6.5604

Div&CapEx Cov

-6.5604

P/BV

0.4369

P/B

0.4369

P/S

31.6492

P/E

-0.5730

P/FCF

-0.7074

P/OCF

-0.8053

P/CF

-0.8053

PEG

-0.0103

P/S

31.6492

EV Multiple

-0.2357

P/FV

0.4369

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation